Porzio Life Sciences is the leading provider of compliance solutions to the life sciences industry, with more than 500 customers including pharmaceutical, biotech and medical device companies.
Our services and solutions simplify compliance for life sciences companies and make it easier for companies to comply with state, federal and global regulations governing marketing and sales in the life sciences industry. All of our compliance technology products and services are informed by our team members’ knowledge as lawyers and compliance professionals in the life sciences industry, and built from the law.
Porzio Life Sciences is a wholly owned subsidiary of Porzio, Bromberg & Newman P.C., a law firm nationally recognized for its litigation and regulatory compliance work for the life sciences industry across more than three decades. Established in 2004 under a different name, Porzio Life Sciences has continued to evolve to meet the needs of our customers and to keep up with the increasingly complex regulatory environment.
"With the pandemic, there has been a lot of government money spent in the life science space, which could lead to an uptick in enforcement actions. Life sciences companies will be focused on management related to their global engagements with healthcare practitioners, healthcare organizations and patient advocacy organizations to have a full view of their data and reporting to ensure they are complying with the laws and regulations.”
-John Patrick Oroho, Executive Vice President and Chief Strategy Officer, Porzio Life Sciences LLC
John Patrick Oroho, Executive Vice President and Chief Strategy Officer
John Patrick Oroho, Executive Vice President and Chief Strategy Officer of Porzio Life Sciences, LLC, meets regularly with companies to identify sales and marketing issues and to propose solutions that streamline their practices in meeting compliance requirements of all 50 states and the District of Columbia.
Mr. Oroho is also a principal of the law firm, Porzio, Bromberg & Newman P.C., and practices in the Life Sciences Compliance and Regulatory Counseling Department. He concentrates his law practice in regulatory compliance with respect to the Prescription Drug Marketing Act (PDMA), Antikickback statute, False Claim Act, and Medicare and Medicaid fraud and abuse.
Previously, he served as Senior Vice President and General Counsel for the PDMA Alliance, a national trade association focused on sample distribution and pharmaceutical marketing and sales compliance. Mr. Oroho has an extensive pharmaceutical regulatory and compliance background. He spent three years as General Counsel for the company now known as QPharma, Inc.
Mr. Oroho received a J.D. from the University of Notre Dame School of Law in 1985 and a B.S. from the United States Merchant Marine Academy, where he graduated with honors in 1978.
Vito A. Gagliardi, Jr., JD, President and CEO
Vito A. Gagliardi, Jr. is President and CEO of Porzio Life Sciences, LLC. Mr. Gagliardi sets the strategic goals of the company and is responsible for evaluating business opportunities such as geographic expansion, joint ventures, partnerships, and acquisitions. Mr. Gagliardi is also the Managing Principal of Porzio, Bromberg & Newman P.C., and President and CEO of the other firm's subsidiaries, Porzio Governmental Affairs and Porzio Compliance Services. In this capacity, he works closely the various management teams to ensure each company's products and services assist clients in operating effectively within today’s complex regulatory and legislative framework.
Mr. Gagliardi received a J.D. from Washington & Lee University School of Law in 1989 and a B.A. from University of Notre Dame in 1986.
Primary Products & Services
Our product suite offers comprehensive global compliance solutions to life sciences companies, helping them with compliance research, spend transparency reporting, and high-risk engagements in jurisdictions around the country and the world—all with world-class support from dedicated regulatory experts.
Porzio Compliance Digest
- The go-to source for analysis of state, federal and global regulations affecting the marketing and sale of pharmaceuticals and medical devices
- Updated daily
- Ten databases, covering all aspects of regulatory compliance
Porzio Third Party Engagement
- Easy-to-implement, highly configurable platform for managing high-risk engagement
- Integrated regulatory guidance from Porzio Compliance Digest
- Quick global deployment across business functions with flexible & configurable workflows
Porzio Global Spend Transparency
- The industry-leading global spend transparency reporting product
- “Built from the law,” ensuring reports are compliant with current regulations in more than 40 jurisdictions around the world
- A true global transparency solution that aggregates data across jurisdictions and business units
Porzio Global Compliance Services
- Distribution, Licensing and Supply Chain
- U.S. & Global Data Privacy Assessments
- U.S. & Global Compliance Monitoring and Audits